AVANOS MEDICAL INC (AVNS) Stock Analyst Earnings Estimates
NYSE:AVNS - New York Stock Exchange, Inc. - US05350V1061 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 820M 10.13% | 673.3M -17.89% | 687.8M 2.15% | 685.44M -0.34% | 708.9M 3.42% | 732.36M 3.31% | |
| EBITDA YoY % growth | 123.7M 124.91% | 53.6M -56.67% | 90.2M 68.28% | 152.18M 68.71% | 166.97M 9.72% | 182.58M 9.35% | |
| EBIT YoY % growth | 76M 355.09% | 7.5M -90.13% | 44.7M 496.00% | 128.93M 188.43% | 144.64M 12.18% | 155.04M 7.19% | |
| Operating Margin | 9.27% | 1.11% | 6.50% | 18.81% | 20.40% | 21.17% | |
| EPS YoY % growth | 1.65 43.48% | 1.38 -16.36% | 1.26 -8.70% | 0.87 -31.19% | 1.12 29.53% | 1.46 29.88% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.18 -49.00% | 0.27 -36.86% | 0.27 4.75% | 0.00 -102.62% | 0.01 -95.73% | 0.01 -95.10% | 0.01 -94.85% | 0.02 461.24% | 0.04 413.65% | 0.05 271.17% |
| Revenue Q2Q % growth | 170.85M 0.26% | 174.93M -2.60% | 176.77M 5.53% | 202.2M 15.54% | 208.58M 22.08% | 214.87M 22.83% | 217.66M 23.13% | 226.8M 12.17% | 233.02M 11.72% | 240.97M 12.15% |
| EBITDA Q2Q % growth | 42.432M -11.60% | 49.062M -23.10% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 117.59M 764.63% | 135.93M 642.79% | 111.19M 979.51% | 175.45M 7.22% | 129.65M 10.26% | 144.32M 6.17% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.17 -41.38% | 0.15 | 0.02 | 11.11% |
| Q1 2025 Q2Q % growth | 0.26 36.84% | 0.18 | 0.08 | 41.61% |
| Q4 2024 Q2Q % growth | 0.42 31.25% | 0.41 | 0.01 | 2.94% |
| Q3 2024 Q2Q % growth | 0.36 -14.29% | 0.36 | 0.00 | -0.30% |
| Q2 2024 Q2Q % growth | 0.29 -21.62% | 0.29 | 0.00 | -0.94% |
| Q1 2024 Q2Q % growth | 0.19 -29.63% | 0.22 | -0.03 | -13.23% |
| Q4 2023 Q2Q % growth | 0.32 -46.67% | 0.37 | -0.05 | -14.44% |
| Q3 2023 Q2Q % growth | 0.42 10.53% | 0.29 | 0.13 | 47.06% |
| Q2 2023 Q2Q % growth | 0.37 -9.76% | 0.30 | 0.07 | 21.73% |
| Q1 2023 Q2Q % growth | 0.27 3.85% | 0.28 | -0.01 | -3.48% |
| Q4 2022 Q2Q % growth | 0.60 30.43% | 0.50 | 0.10 | 20.05% |
| Q3 2022 Q2Q % growth | 0.38 52.00% | 0.36 | 0.02 | 5.69% |
| Q2 2022 Q2Q % growth | 0.41 95.24% | 0.39 | 0.02 | 5.23% |
| Q1 2022 Q2Q % growth | 0.26 13.04% | 0.27 | -0.01 | -1.96% |
| Q4 2021 Q2Q % growth | 0.46 64.29% | 0.41 | 0.05 | 12.18% |
| Q3 2021 Q2Q % growth | 0.25 19.05% | 0.31 | -0.06 | -18.75% |
| Q2 2021 Q2Q % growth | 0.21 61.54% | 0.24 | -0.03 | -11.76% |
| Q1 2021 Q2Q % growth | 0.23 43.75% | 0.19 | 0.04 | 21.89% |
| Q4 2020 Q2Q % growth | 0.28 -17.65% | 0.22 | 0.06 | 26.69% |
| Q3 2020 Q2Q % growth | 0.21 -30.00% | 0.10 | 0.11 | 105.88% |
| Q2 2020 Q2Q % growth | 0.13 -53.57% | -0.10 | 0.23 | 227.45% |
| Q1 2020 Q2Q % growth | 0.16 6.67% | 0.16 | 0.00 | -0.40% |
| Q4 2019 Q2Q % growth | 0.34 | 0.32 | 0.02 | 5.40% |
| Q3 2019 Q2Q % growth | 0.30 | 0.32 | -0.02 | -5.88% |
| Q2 2019 Q2Q % growth | 0.28 | 0.29 | -0.01 | -2.40% |
| Q1 2019 Q2Q % growth | 0.15 | 0.14 | 0.01 | 10.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 175M 1.92% | 168.81M | 6.19M | 3.67% |
| Q1 2025 Q2Q % growth | 167.5M 0.84% | 164.99M | 2.51M | 1.52% |
| Q4 2024 Q2Q % growth | 179.6M 3.64% | 180.8M | -1.2M | -0.66% |
| Q3 2024 Q2Q % growth | 170.4M -0.53% | 178.84M | -8.44M | -4.72% |
| Q2 2024 Q2Q % growth | 171.7M 1.36% | 174.08M | -2.38M | -1.37% |
| Q1 2024 Q2Q % growth | 166.1M -13.35% | 166.16M | -60K | -0.04% |
| Q4 2023 Q2Q % growth | 173.3M -20.32% | 173.84M | -540K | -0.31% |
| Q3 2023 Q2Q % growth | 171.3M -0.58% | 172.99M | -1.69M | -0.98% |
| Q2 2023 Q2Q % growth | 169.4M -0.88% | 189.95M | -20.55M | -10.82% |
| Q1 2023 Q2Q % growth | 191.7M 20.34% | 199.1M | -7.4M | -3.72% |
| Q4 2022 Q2Q % growth | 217.5M 12.46% | 221.65M | -4.15M | -1.87% |
| Q3 2022 Q2Q % growth | 172.3M -6.41% | 209.58M | -37.28M | -17.79% |
| Q2 2022 Q2Q % growth | 170.9M -8.32% | 212.44M | -41.54M | -19.55% |
| Q1 2022 Q2Q % growth | 159.3M -11.84% | 201.76M | -42.46M | -21.04% |
| Q4 2021 Q2Q % growth | 193.4M 4.54% | 195.15M | -1.75M | -0.90% |
| Q3 2021 Q2Q % growth | 184.1M -0.86% | 189.05M | -4.95M | -2.62% |
| Q2 2021 Q2Q % growth | 186.4M 13.87% | 184.17M | 2.23M | 1.21% |
| Q1 2021 Q2Q % growth | 180.7M 0.17% | 178.95M | 1.75M | 0.98% |
| Q4 2020 Q2Q % growth | 185M -2.53% | 187.83M | -2.83M | -1.51% |
| Q3 2020 Q2Q % growth | 185.7M 8.34% | 169.18M | 16.52M | 9.76% |
| Q2 2020 Q2Q % growth | 163.7M -4.94% | 150.86M | 12.84M | 8.51% |
| Q1 2020 Q2Q % growth | 180.4M 9.87% | 178.72M | 1.68M | 0.94% |
| Q4 2019 Q2Q % growth | 189.8M | 184.69M | 5.11M | 2.77% |
| Q3 2019 Q2Q % growth | 171.4M | 183.44M | -12.04M | -6.56% |
| Q2 2019 Q2Q % growth | 172.2M | 175.25M | -3.05M | -1.74% |
| Q1 2019 Q2Q % growth | 164.2M | 167.3M | -3.1M | -1.85% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -37.5% | 0% | -24.44% |
| Revenue | 0% | -1.64% | 0% | -0.22% |